-
Mashup Score: 22Episode 155: Brighter Days Ahead - 23 day(s) ago
In “Brighter Days Ahead,” Dr. Osterholm and Chris Dall discuss the latest national and international COVID trends, recent research on long COVID, and measles cases in the U.S. Dr. Osterholm also shares the latest “This Week in Public Health History” segment and interviews two members of the podcast team. Please fill out our Listener Feedback Survey! Three studies spotlight long-term burden of COVID in US adults (Van Beusekom, CIDRAP News) Lessons in persistence: new long COVID trials aim to clear lingering virus—and help patients in dire need (Couzin-Frankel, Science) The pandemic’s true death toll (The Economist) Superbugs & You podcast More episodes Support this podcast
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 8COVID-19 antibody discovery could explain long COVID - 1 month(s) ago
Researchers discover that the COVID-19 virus can trigger the production of “abzymes” — antibodies that act like enzymes — which may explain why long COVID symptoms persist even after the infection is cleared.
Source: www.eurekalert.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 35Episode 153: Good News in a COVID Indifferent World - 2 month(s) ago
In “Good News in a COVID Indifferent World,” Dr. Osterholm and Chris Dall discuss the national and international COVID trends, the latest research on long COVID, and antibiotic resistant Shigella. Dr. Osterholm also shares the latest “This Week in Public Health History” segment and interviews members of the podcast team. Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19 (Hanson et al., Nature Immunology) How Americans view the coronavirus, COVID-19 vaccines amid declining levels of concern (Tyson & Pasquini, Pew Research Center) Spike in extensively drug-resistant Shigella cases reported in UK, Europe (Dall, CIDRAP News) CDC warns of increase in extensively drug-resistant shigellosis (Dall, CIDRAP News) Superbugs & You podcast — new episode coming 3/26! The man in the iron lung (McRobbie, The Guardian) More episodes Support this podcast
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 350Global webinar series on post COVID-19 condition - 2 month(s) ago
Practical strategies for symptom management in post COVID-19 condition
Source: www.who.intCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 42Episode 149: A Period of Transition - 4 month(s) ago
In “A Period of Transition,” Dr. Osterholm and Chris Dall discuss the latest COVID-19 trends in the U.S. and around the world, a recent study on long COVID, and the rise of measles cases in the United States. Dr. Osterholm also provides an update on influenza and RSV cases in the U.S. and shares the latest “This Week in Public Health History” segment. Persistent complement dysregulation with signs of thromboinflammation in active long COVID (Cervia-Hasler et al., Science) Lighting up long COVID (Eric Topol, Ground Truths) Follow up, funding critical on long COVID (Jill Burcum, Star Tribune) Does Paxlovid prevent long COVID? Maybe, experts suggest (Stephanie Soucheray, CIDRAP News)
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 146Scientist Brendan Crabb caught COVID by breaking his own rule. This is how he avoided it for so long - 4 month(s) ago
Three of Australia’s leading COVID experts share their personal COVID safety strategies and reflect on what must happen if we’re to blunt the growing health crisis the pandemic is causing — and prepare for the next one.
Source: www.abc.net.auCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 30
The most common symptoms were cough, fatigue, and memory loss.
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 30
The most common symptoms were cough, fatigue, and memory loss.
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 219
This revised Roadmap takes into account increasing vaccine availability, vaccine coverage rates, and the evolving epidemiological situation including COVID-19 variants of concern. Scenarios in which vaccination coverage exceeds 50% of the population are considered, as are topics such as vaccine use in children and adolescents and prioritization of additional and booster doses in relation to vaccination coverage rates. To assist countries in developing recommendations for optimized use of vaccines against COVID-19,priority-use groups for vaccination (both primary series and booster doses) are identified based on epidemiological scenarios, public health goals, and vaccine coverage scenarios.
Source: www.who.intCategories: General Medicine News, Infectious DiseaseTweet
New "Osterholm Update" podcast episode! @mtosterholm & @cvdall discuss national & global #COVID19 trends, research on #LongCOVID, US measles cases, & "This Week in Public Health History," plus interviews w/ 2 members of the podcast team https://t.co/sDj9LbuNr9 https://t.co/W0OkklPASt